sfa 15:0

Pentadecanoic acid, commonly designated SFA 15:0 or C15:0, is an odd‑chain saturated fatty acid composed of a linear chain of fifteen carbon atoms with no double bonds, giving it the classification 15:0 in lipid notation. Unlike the more common even‑chain saturated fats such as palmitic (C16:0) and stearic (C18:0) acids, pentadecanoic acid has an odd number of carbons, which affects its metabolic handling by the body. Pentadecanoic acid is found in trace amounts in specific foods — most notably in dairy fat, grass‑fed ruminant meat, and certain marine sources — and historically has been used in laboratory analyses as an internal standard for fatty acid quantification due to its relative rarity in the diet. The molecular formula for pentadecanoic acid is C15H30O2, and structurally it consists of a straight hydrocarbon chain terminated with a carboxyl group. Because the human body does not synthesize pentadecanoic acid in appreciable amounts, it must be obtained from dietary sources. Unlike linoleic and alpha‑linolenic acids, which are officially classified as essential fatty acids due to strict dietary requirements and deficiency syndromes, pentadecanoic acid is not currently recognized by major nutrition authorities with an established recommended daily allowance (RDA). Nonetheless, emerging evidence indicates that circulating levels of C15:0 are associated with beneficial metabolic outcomes, prompting a reevaluation of its nutritional significance. Researchers have observed that higher levels of pentadecanoic acid in plasma phospholipids or red blood cell membranes correlate with more favorable cardiometabolic health markers, including lower risks of type 2 diabetes and cardiovascular disease, which has generated interest in its role beyond a simple dietary biomarker. Pentadecanoic acid is thus best understood as a bioactive fatty acid with unique metabolic signatures that distinguish it from other saturated fats whose effects on lipid profiles and health outcomes have been more extensively studied. Its identification and quantification in foods and biological tissues rely on advanced lipidomic techniques, reflecting its importance in contemporary nutritional biochemistry research.

Emerging scientific evidence suggests that pentadecanoic acid (SFA 15:0) may have physiologic roles distinct from conventional even‑chain saturated fats. Research reported in nutrient biochemistry journals indicates that C15:0 activates key metabolic regulators like AMP‑activated protein kinase (AMPK) while inhibiting mechanistic target of rapamycin (mTOR), pathways intimately involved in energy homeostasis, cellular metabolism, and longevity signaling. Studies have shown that these actions can result in lowered pro‑inflammatory cytokines and improved metabolic flexibility. In cellular models, C15:0 has demonstrated anti‑inflammatory and antifibrotic activities, reducing markers such as MCP‑1, TNF‑α, and interleukin families, which align with improved metabolic health markers and potentially reduced chronic inflammation in vivo. Moreover, epidemiological data link higher circulating concentrations of pentadecanoic acid to lower incidence rates of cardiometabolic disorders, including type 2 diabetes and nonalcoholic fatty liver disease, suggesting systemic benefits when adequate levels are maintained. One cross‑sectional meta‑analysis of biomarkers showed inverse associations between odd‑chain saturated fatty acid plasma levels and cardiometabolic disease risk markers. Animal and human observational studies have also demonstrated potential benefits in lipid metabolism. C15:0 may enhance lipid oxidation and mitigate dyslipidemia, as evidenced by reductions in LDL cholesterol in some cohorts, although the mechanisms remain under active investigation. Importantly, pentadecanoic acid’s role in membrane structure may influence cell resilience, as its incorporation into membrane phospholipids could modulate fluidity and oxidative stability, contributing to healthier aging phenotypes. While saturated fatty acids have often been broadly characterized as detrimental to cardiovascular health, recent research highlights the need to differentiate between specific molecular species. For instance, a 2023 lipidomics study underscores that odd‑chain saturated fatty acids like C15:0 behave differently from even‑chain counterparts in metabolic pathways and health correlations. Pentadecanoic acid has been shown in experimental models to reduce liver inflammation and markers of metabolic dysfunction, including insulin resistance, suggesting a potential protective role in metabolic syndrome. Taken together, these findings support the hypothesis that pentadecanoic acid may operate as a conditionally essential nutrient with specific health benefits, although definitive clinical recommendations await further controlled human trials.

Unlike vitamins and minerals, pentadecanoic acid lacks an official RDA or Adequate Intake level from major nutrition authorities such as the NIH Office of Dietary Supplements. Nevertheless, researchers investigating circulating levels necessary to elicit biologically relevant outcomes have proposed target intake ranges based on observational and mechanistic studies. Experimental analyses suggest that maintaining circulating C15:0 concentrations in the range of approximately 10 to 30 µM may be associated with favorable metabolic and cardiovascular profiles, and dietary intakes of roughly 100 to 300 mg/day may help achieve these levels. It is important to recognize that these proposed intake ranges derive from research contexts rather than regulatory guidance and represent initial approximations pending more robust clinical trials. Dietary requirements for fatty acids like pentadecanoic acid are influenced by multiple factors, including age, sex, metabolic status, and habitual diet composition. Individuals with higher metabolic demands or altered lipid metabolism — such as those with insulin resistance or nonalcoholic fatty liver disease — could theoretically benefit from dietary patterns that provide consistent but moderate amounts of odd‑chain fatty acids. Because pentadecanoic acid is obtained exclusively through diet, the amount consumed will vary according to the types of fats present in a person’s diet. Full‑fat dairy products and ruminant meats typically contain higher concentrations of C15:0 relative to other foods, making them primary contributors to daily intake. In the absence of formal intake recommendations, dietary strategies emphasize food sources that naturally contain pentadecanoic acid as part of balanced nutrition. For example, incorporation of whole‑fat dairy, certain fish, and grass‑fed meats may increase C15:0 intake. Given that pentadecanoic acid exists in foods as part of complex lipid matrices, total fat intake and the broader nutrient profile of foods should be considered to balance overall dietary recommendations for cardiovascular health and metabolic risk.

Because pentadecanoic acid is not officially recognized with an established deficiency syndrome by major authorities, specific clinical deficiency signs have not been clearly defined. However, observational research suggests that chronically low circulating concentrations of C15:0 may correlate with suboptimal metabolic health markers, including higher inflammatory cytokines, impaired insulin sensitivity, dyslipidemia, and increased risk profiles for type 2 diabetes and cardiovascular disease. Cross‑sectional studies comparing individuals with low vs. higher plasma odd‑chain fatty acid levels indicate that lower C15:0 is associated with poorer cardiometabolic health indices, though causality cannot be definitively determined from these associations. Because pentadecanoic acid is a component of cell membrane lipids, low levels might hypothetically compromise membrane integrity and resilience, contributing to premature cellular dysfunction, although this remains speculative in human clinical contexts. Certain at‑risk populations, such as individuals with very low intake of full‑fat dairy or ruminant meats due to dietary restrictions, may exhibit lower circulating levels, which have been epidemiologically linked with less favorable metabolic markers. It is critical to emphasize that these correlations do not represent classical nutrient deficiency diseases such as scurvy or rickets but rather reflect potential associations with broader metabolic dysfunction. Further research is required to determine whether low C15:0 status independently contributes to pathophysiological processes or merely serves as a marker of overall dietary patterns that are suboptimal for metabolic health.

Pentadecanoic acid is present in trace amounts in a variety of animal‑derived fats and selected marine foods. The richest dietary sources are dairy fats: butter, whole milk, cream, and cheese contain measurable C15:0 concentrations as part of their saturated fat profiles. Grass‑fed dairy and meats tend to have higher odd‑chain fatty acid content than grain‑fed equivalents due to differences in ruminal microbial fermentation and fatty acid synthesis in ruminants. Other sources include fatty fish species, albeit at lower concentrations. Plant sources generally contain minimal pentadecanoic acid except where included as minor components of mixed fats. Because pentadecanoic acid accounts for roughly 0.5–1.5% of total fat in dairy and ruminant products, the absolute amount per serving depends on food fat content. Incorporating full‑fat dairy and grass‑fed meats into the diet is the most practical way to raise intake of C15:0. It is crucial to balance these sources within overall dietary patterns that prioritize cardiovascular health, given that saturated fat intake in excess has long been associated with elevated LDL cholesterol and increased cardiovascular risk in population studies. A comprehensive table below outlines specific food sources and their approximate C15:0 content.

Pentadecanoic acid, like other long‑chain fatty acids, is absorbed in the small intestine following emulsification by bile salts. It is incorporated into micelles, transported across enterocytes, and packaged into chylomicrons for lymphatic transport into the circulation. Because C15:0 is part of complex triglycerides, the presence of dietary fat stimulates secretion of bile and pancreatic lipases, enhancing its absorption when consumed with other lipids. Bioavailability is influenced by the food matrix; consumption of dairy and meat fats typically leads to efficient uptake. There is no evidence that other dietary components significantly block C15:0 absorption, although diets extremely low in fat may limit its assimilation. Once in circulation, odd‑chain fatty acids can be incorporated into phospholipids of cell membranes and red blood cells, where they may exert effects on membrane properties and signaling pathways. Because pentadecanoic acid is lipid‑soluble, consuming it with meals containing fat may optimize bioavailability and distribution throughout tissues.

Commercial supplements containing purified pentadecanoic acid (often marketed as "C15:0" or branded forms) have emerged based on early research linking higher circulating levels with health benefits. However, no major nutrition authority endorses specific dosing, and clinical trial evidence remains limited. Those considering supplements should consult healthcare professionals, especially individuals with lipid disorders or existing cardiovascular conditions.

There is no officially established tolerable upper intake level for pentadecanoic acid, and research has not identified specific toxicity thresholds. Because C15:0 is a minor component of dietary fat, even high intakes from supplements would contribute modestly to overall saturated fat load.

Because pentadecanoic acid affects metabolic pathways such as AMPK and mTOR, theoretical interactions with medications targeting glucose metabolism (e.g., metformin) or lipid‑lowering therapies may exist, though specific interactions have not been well‑characterized.

Common Forms: C15:0 purified oil, microalgae‑derived C15:0

Typical Doses: 100–300 mg/day referenced in research

When to Take: with meals containing fat

Best Form: triglyceride esterified pentadecanoic acid in dietary fats